Brief: Angelini Pharma And Jcr Pharmaceuticals Announce Global Collaboration For The Development And Commercialization Of Novel Biologic Therapies In Epilepsy

JCR Pharmaceuticals

11/05/2023 12:47

May 11 (Reuters) - JCR Pharmaceuticals Co Ltd  4552.T :
    * ANGELINI PHARMA AND JCR PHARMACEUTICALS ANNOUNCE GLOBAL
COLLABORATION FOR THE DEVELOPMENT AND COMMERCIALIZATION OF NOVEL
BIOLOGIC THERAPIES IN EPILEPSY
    * JCR PHARMACEUTICALS CO LTD- UNDER TERMS OF AGREEMENT, JCR
WILL
RECEIVE REIMBURSEMENT OF RESEARCH EXPENSES AND AN UPFRONT
PAYMENT
    * JCR PHARMACEUTICALS CO- UNDER DEAL, JCR ELIGIBLE TO
RECEIVE
ADDITIONAL PAYMENTS OF UP TO $505.5 MILLION UPON REACHING
DEVELOPMENT, COMMERCIAL MILESTONES

Source text for Eikon:  ID:nBw6Cbsm1a 
Further company coverage:  4552.T 

 ((Reuters.Briefs@thomsonreuters.com;))